Home > Healthcare > Medical Devices > Therapeutic Devices > Ventricular Assist Devices Market
Ventricular Assist Devices Market Size
- Report ID: GMI3014
- Published Date: Oct 2019
- Report Format: PDF
Ventricular Assist Devices Market Size
Ventricular Assist Devices Market size exceeded USD 2.2 billion in 2018 and is set to register over 6.3% CAGR up to 2025. Ventricular assist devices, also known as the mechanical circulatory support (MCS) device are implantable mechanical pump that assist in pumping the blood from the lower chambers of the heart to the rest of the body.
The ventricular assist devices are majorly used in patients that have weak heart or are suffering from heart failure. These devices can be placed in either left, right or both ventricles of the heart, however, it is most commonly used in the left ventricle. The major applications of ventricular assist devices are when the patient is waiting for a heart transplant (short-term treatment) or when the patient is not eligible for heart transplant but needs circulatory support (long-term treatment). The procedure involving ventricular assist device implantation often requires open heart surgery and does have several risks associated with it. However, the use of ventricular assist devices can be life saving for a person suffering from several heart failure and other cardiovascular disease.
| Report Attribute | Details |
|---|---|
| Base Year: | 2018 |
| Ventricular Assist Devices Market Size in 2018: | 2.2 Billion (USD) |
| Forecast Period: | 2019 to 2025 |
| Forecast Period 2019 to 2025 CAGR: | 6.3% |
| 2025 Value Projection: | 3.5 Billion (USD) |
| Historical Data for: | 2014 to 2018 |
| No. of Pages: | 300 |
| Tables, Charts & Figures: | 700 |
| Segments covered: | Product, Application, Age, Flow and Design |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Ventricular assist devices offer several lifesaving therapies to patients that suffer from end-stage heart failure and for whom heart donor is not available. There are a number of ventricular assist devices currently available in the market, however, several challenges and restraining factors such as high cost and health risk affect the adoption rate of the devices. End-stage heart failure affects around 6 million Americans annually and is responsible for heavy healthcare burden on several countries. Despite several advances in healthcare therapies, it is estimated that around one million people will suffer from heart failure with high mortality rates. In the last few years, left ventricular assist devices have transitioned from bridge-to-transplant therapy to destination therapy for the patients suffering from advanced heart failure.
Frequently Asked Questions (FAQ) :
Ventricular Assist Devices Market Scope
